[HTML][HTML] Scientific advances in lung cancer 2015
Lung cancer continues to be a major global health problem; the disease is diagnosed in
more than 1.6 million new patients each year. However, significant progress is underway in …
more than 1.6 million new patients each year. However, significant progress is underway in …
A critical review of recent developments in radiotherapy for non-small cell lung cancer
S Baker, M Dahele, FJ Lagerwaard, S Senan - Radiation oncology, 2016 - Springer
Lung cancer is the leading cause of cancer mortality, and radiotherapy plays a key role in
both curative and palliative treatments for this disease. Recent advances include stereotactic …
both curative and palliative treatments for this disease. Recent advances include stereotactic …
SUNSET: Stereotactic radiation for ultracentral non–small-cell lung cancer—A safety and efficacy trial
Background Lung stereotactic body radiotherapy (SBRT) is considered a standard curative
treatment for medically inoperable early stage non–small-cell lung cancer (NSCLC) …
treatment for medically inoperable early stage non–small-cell lung cancer (NSCLC) …
Organs at risk considerations for thoracic stereotactic body radiation therapy: What is safe for lung parenchyma?
Purpose Stereotactic body radiation therapy (SBRT) has become the standard of care for
inoperable early-stage non-small cell lung cancer and is often used for recurrent lung …
inoperable early-stage non-small cell lung cancer and is often used for recurrent lung …
A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer
Stereotactic ablative body radiotherapy (SABR) describes a radiotherapy (RT) technique
where high doses of radiation are precisely delivered to an extracranial target within the …
where high doses of radiation are precisely delivered to an extracranial target within the …
[HTML][HTML] Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and …
TP Diwanji, P Mohindra, M Vyfhuis… - … lung cancer research, 2017 - ncbi.nlm.nih.gov
The 21st century has seen several paradigm shifts in the treatment of non-small cell lung
cancer (NSCLC) in early-stage inoperable disease, definitive locally advanced disease, and …
cancer (NSCLC) in early-stage inoperable disease, definitive locally advanced disease, and …
[HTML][HTML] Combining stereotactic body radiation therapy with immunotherapy: current data and future directions
Stereotactic body radiation therapy (SBRT) offers excellent local control of early-stage non-
small cell lung cancer (NSCLC), but there currently is a need for tolerable systemic therapy …
small cell lung cancer (NSCLC), but there currently is a need for tolerable systemic therapy …
[HTML][HTML] The evolving toxicity profile of SBRT for lung cancer
M Thompson, KE Rosenzweig - Translational lung cancer research, 2019 - ncbi.nlm.nih.gov
Stereotactic body radiation therapy (SBRT) is an effective and well tolerated treatment for
early stage non-small cell lung cancer (NSCLC). The high doses used in thoracic SBRT can …
early stage non-small cell lung cancer (NSCLC). The high doses used in thoracic SBRT can …
The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors
Background and purpose Recent studies have postulated that patients undergoing lung
stereotactic body radiotherapy (SBRT) for ultracentral tumors have higher toxicity and …
stereotactic body radiotherapy (SBRT) for ultracentral tumors have higher toxicity and …
[HTML][HTML] Concomitant chemotherapy and radiotherapy with SBRT boost for unresectable stage III non–small cell lung cancer: a phase I study
Objectives Stereotactic body radiation therapy (SBRT) is now the standard of care in
medically inoperable stage I NSCLC, yielding high rates of local control. It is unknown …
medically inoperable stage I NSCLC, yielding high rates of local control. It is unknown …